Royston, United Kingdom

Raymond George Hill


Average Co-Inventor Count = 1.4

ph-index = 3

Forward Citations = 116(Granted Patents)


Company Filing History:


Years Active: 1999-2003

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Raymond George Hill

Introduction

Raymond George Hill is a notable inventor based in Royston, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the body. With a total of four patents to his name, Hill's work has the potential to impact therapeutic practices significantly.

Latest Patents

One of Hill's latest patents is titled "Benzimidazolinyl piperidines as CGRP ligands." This invention relates to benzimidazolinylpiperidine derivatives that are useful as ligands for CGRP (Calcitonin Gene-Related Peptide) receptors. The patent outlines their therapeutic applications, pharmaceutical compositions that include these compounds, and methods of treatment utilizing them. Another significant patent is for a "Tachykinin antagonist and an opioid analgesic effective at treating pain or nociception." This invention describes methods and compositions for alleviating pain and nociception in patients by administering a combination of a morpholine or thiomorpholine tachykinin antagonist along with an opioid analgesic.

Career Highlights

Throughout his career, Hill has worked with prominent organizations, including Merck Sharp & Dohme Corporation. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Hill has collaborated with notable individuals in his field, including Arthur A Patchett and Lihu Yang. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Raymond George Hill's contributions to pharmaceutical innovation are noteworthy, particularly in the development of compounds that target specific receptors for therapeutic use. His patents reflect a commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…